Funding Opportunities Overview
The National Human Genome Research Institute solicits grant applications related to its scientific priorities and welcomes investigator-initiated applications.
Apply for Research Funding
Last updated: July 31, 2024
Scan to visit
The National Human Genome Research Institute solicits grant applications related to its scientific priorities and welcomes investigator-initiated applications.
The National Human Genome Research Institute (NHGRI) solicits grant applications that relate to its scientific priorities and research interests. For some programs, the NHGRI participates with other institutes and centers at the National Institutes of Health (NIH). All NIH solicitations are published weekly as articles in the NIH Guide for Grants and Contracts and archived by date and announcement category. The archive can be browsed, or searched by keyword.
NHGRI welcomes innovative investigator-initiated applications and encourages investigators with novel ideas to discuss potential applications with program staff during the concept development stage of the application.
Investigator-initiated research applications follow the NIH standard schedule for submission, review and award.
**Note: Multiple changes in 2025 affect the submission and review of NIH grant applications. Learn more about these updates on the NIH Office of Extramural Research website: Changes Coming to NIH Applications and Peer Review in 2025.
If you are considering submitting an application, please contact NHGRI staff during the concept development phase of your application. This makes it more likely that your proposed research will be appropriate for NHGRI's research mission. Program staff members are very receptive to discussing your ideas and how they fit within the research mission of NHGRI.
Locate the appropriate staff by using the Content Map for Contacts by Research Area or the Contacts by Research Area: Search.
You can search for contacts by visiting the any of the following pages for the divisions that make up the Extramural Research Program (ERP):
Connect with staff in Training, Diversity and Health Equity Office, who works to champion a diverse genomics workforce, address health disparities and reach a more equitable and healthy society.
Connect with staff in the Office of Genomic Data Science, who provide leadership, strategic guidance, and coordination for NHGRI activities, programs, and policies in genomic data science.
Program announcements (PA)
Describes new, continuing, or expanded scientific priorities and program areas, follow the standard schedule for submission, review and award and are usually active for three years.
Program announcements with special receipt dates (PAR)
Provide their own submission schedules and are usually active for three years.
Request for Applications (RFA)
Describe an institute's or center's interest in receiving applications in specific area(s). These are usually one-time solicitations.
The National Human Genome Research Institute (NHGRI) has established listservs to announce funding opportunities, other relevant federal notices, NHGRI policies, and courses that receive support from NHGRI. Subscribers receive brief summaries of Program Announcements (PAs) and Requests for Applications (RFAs), Notices, etc. with links to more detailed information.
To receive information about research in genomics science, subscribe to https://list.nih.gov/archives/nhgribulletin-l.html.
To receive information related to Ethical, Legal and Social Implications (ELSI) Research, send an e-mail to: ELSI@nhgri.nih.gov and indicate that you would like to subscribe to the ELSI list.
You may subscribe to both listservs.
NIH offers a subscription service for those interested in a customized list of NIH Funding Opportunity Announcements.
On the NIH Guide Advanced Search page, enter search terms and topics of interest to you, and click "Search." On the next page, you will be able to save the search and have results sent to you periodically.
Last updated: July 31, 2024
Sickle Cell Reproductive Health Education Directive (SC RED) advocates for high quality sexual and reproductive health care for individuals living with all types of sickle cell disease
Receive updates, news and other related topics to your email address